Published in Invest Ophthalmol Vis Sci on July 01, 1994
Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2007) 1.29
Evaluation of corneal graft rejection in a mouse model. Br J Ophthalmol (2002) 1.20
Allergic airway hyperreactivity increases the risk for corneal allograft rejection. Am J Transplant (2009) 1.04
Allergic conjunctivitis exacerbates corneal allograft rejection by activating Th1 and th2 alloimmune responses. J Immunol (2010) 0.97
Two different regulatory T cell populations that promote corneal allograft survival. Invest Ophthalmol Vis Sci (2010) 0.96
Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium. Br J Ophthalmol (1999) 0.78
Adhesion molecule expression in local-macrophage-depleted rats bearing orthotopic corneal allografts. Graefes Arch Clin Exp Ophthalmol (2003) 0.76
IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol (2009) 2.65
Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med (1981) 1.63
Oral immunisation as a strategy for enhancing corneal allograft survival. Br J Ophthalmol (1997) 1.51
Spontaneous corneal neovascularization in nude mice. Local imbalance between angiogenic and anti-angiogenic factors. Invest Ophthalmol Vis Sci (1993) 1.41
Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J Immunol (1998) 1.40
Resistance of Acanthamoeba castellanii cysts to physical, chemical, and radiological conditions. J Parasitol (2002) 1.40
Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells. J Immunol (1985) 1.38
Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest Ophthalmol Vis Sci (1991) 1.34
Anterior chamber-associated immune deviation promotes corneal allograft survival. Invest Ophthalmol Vis Sci (1996) 1.33
A novel role for TGF-beta and IL-10 in the induction of immune privilege. J Immunol (1998) 1.30
Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID). Immunology (1998) 1.23
Effect of steroids on Acanthamoeba cysts and trophozoites. Invest Ophthalmol Vis Sci (2001) 1.21
Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens. J Exp Med (1980) 1.21
In vivo and in vitro collagenolytic activity of Acanthamoeba castellanii. Invest Ophthalmol Vis Sci (1990) 1.21
Ocular disease induced in mice by anterior chamber inoculation of herpes simplex virus. Invest Ophthalmol Vis Sci (1984) 1.19
Role of antibody and complement in the control of Encephalitozoon cuniculi infections by rabbit macrophages. Infect Immun (1980) 1.19
In vitro and in vivo tumoricidal properties of a pathogenic/free-living amoeba. Cancer Lett (1993) 1.19
Mannose induces the release of cytopathic factors from Acanthamoeba castellanii. Infect Immun (1998) 1.17
Gamma delta T cells are needed for ocular immune privilege and corneal graft survival. J Immunol (2001) 1.10
The role of macrophages in Acanthamoeba keratitis. Invest Ophthalmol Vis Sci (1996) 1.08
Antigenic cross-reactivity among different microsporidan spores as determined by immunofluorescence. J Parasitol (1980) 1.06
Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model. Invest Ophthalmol Vis Sci (1995) 1.05
Allergic airway hyperreactivity increases the risk for corneal allograft rejection. Am J Transplant (2009) 1.04
The role of contact lenses, trauma, and Langerhans cells in a Chinese hamster model of Acanthamoeba keratitis. Invest Ophthalmol Vis Sci (1993) 1.04
Susceptibility of selected inbred strains of mice to Encephalitozoon cuniculi. J Infect Dis (1981) 1.04
Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells. J Immunol (2000) 1.03
Characterization and pathogenic potential of a soil isolate and an ocular isolate of Acanthamoeba castellanii in relation to Acanthamoeba keratitis. Curr Eye Res (1992) 1.03
Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors. J Immunol (1987) 1.03
Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses. J Immunol (1983) 1.02
Apoptosis as a mechanism of cytolysis of tumor cells by a pathogenic free-living amoeba. Infect Immun (1994) 1.02
Analysis of antibody production induced by allogeneic tumor cells inoculated into the anterior chamber of the eye. Transplantation (1982) 0.99
Intracameral inoculation of herpes simplex virus type I induces anterior chamber associated immune deviation. Curr Eye Res (1983) 0.99
Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1. J Immunol (2001) 0.98
The effect of oral immunization on corneal allograft survival. Transplantation (1996) 0.97
Phagocytosis of particulate antigens by corneal epithelial cells stimulates interleukin-1 secretion and migration of Langerhans cells into the central cornea. Reg Immunol (1990) 0.97
Acanthamoeba keratitis. CLAO J (1995) 0.96
Tear IgA and serum IgG antibodies against Acanthamoeba in patients with Acanthamoeba keratitis. Cornea (2001) 0.96
The role of cytotoxic T lymphocytes in corneal allograft rejection. Invest Ophthalmol Vis Sci (2000) 0.95
Characterization of a plasminogen activator produced by Acanthamoeba castellanii. Mol Biochem Parasitol (1995) 0.95
The diagnosis and management of Acanthamoeba keratitis. CLAO J (2000) 0.94
Autoimmunity at the ocular surface: pathogenesis and regulation. Mucosal Immunol (2010) 0.93
A pig model of Acanthamoeba keratitis: transmission via contaminated contact lenses. Invest Ophthalmol Vis Sci (1992) 0.93
Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye. J Immunol (1996) 0.93
Role of mucosal IgA in the resistance to Acanthamoeba keratitis. Invest Ophthalmol Vis Sci (1998) 0.93
Role of Th1 and Th2 cells in anterior chamber-associated immune deviation. Immunology (1996) 0.93
Systemic immune response to Acanthamoeba keratitis in the Chinese hamster. Ocul Immunol Inflamm (1997) 0.92
In vitro characterization of Acanthamoeba castellanii cytopathic effect. J Parasitol (1995) 0.91
Inhibition of intraocular tumor growth by topical application of the angiostatic steroid anecortave acetate. Invest Ophthalmol Vis Sci (1999) 0.90
IFN-γ blocks CD4+CD25+ Tregs and abolishes immune privilege of minor histocompatibility mismatched corneal allografts. Am J Transplant (2013) 0.90
Immunologic evaluation of spontaneous regression of an intraocular murine melanoma. Invest Ophthalmol Vis Sci (1990) 0.90
Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis. Immunology (1995) 0.90
Local inhibition of natural killer cell activity promotes the progressive growth of intraocular tumors. Invest Ophthalmol Vis Sci (1997) 0.89
Spontaneous immune rejection of intraocular tumors in mice. Invest Ophthalmol Vis Sci (1985) 0.89
Angiostatin produced by certain primary uveal melanoma cell lines impedes the development of liver metastases. Arch Ophthalmol (2001) 0.89
Expression of HLA class I and II antigens on cells of the human trabecular meshwork. Ophthalmology (1987) 0.89
Tissue-type plasminogen activator-induced invasion and metastasis of murine melanomas. Curr Eye Res (1995) 0.88
Effect of anti-ganglioside antibodies on the metastatic spread of intraocular melanomas in a nude mouse model of human uveal melanoma. Curr Eye Res (1993) 0.88
Antibody-dependent neutrophil-mediated killing of Acanthamoeba castellanii. Int J Parasitol (1994) 0.88
Heterotopic corneal grafting in mice: a new approach to the study of corneal alloimmunity. Invest Ophthalmol Vis Sci (1982) 0.87
The presence of donor-derived class II-positive cells abolishes immune privilege in the anterior chamber of the eye. Transplantation (1991) 0.87
Immunogenetic basis for immunologic privilege in the anterior chamber of the eye. Immunogenetics (1981) 0.86
Enhanced natural killer cell activity in experimental murine encephalitozoonosis. Infect Immun (1983) 0.86
Induction of anterior chamber-associated immune deviation (ACAID) by allogeneic intraocular tumors does not require splenic metastases. J Immunol (1982) 0.86
Depletion of donor-derived Langerhans cells promotes corneal allograft survival. Cornea (1996) 0.86
Characterization of intraocular tumors arising in transgenic mice. Invest Ophthalmol Vis Sci (1994) 0.86
Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model. Invest Ophthalmol Vis Sci (1996) 0.86
Successful immunization against Acanthamoeba keratitis in a pig model. Cornea (1995) 0.86
Characteristics of rejection of orthotopic corneal allografts in the rat. Transplantation (1988) 0.86
Chemotactic response of macrophages to Acanthamoeba castellanii antigen and antibody-dependent macrophage-mediated killing of the parasite. J Parasitol (1992) 0.86
Oral immunization with Acanthamoeba castellanii mannose-binding protein ameliorates amoebic keratitis. Infect Immun (2006) 0.85
Suppressed cellular immunity in mice harboring intraocular melanomas. Invest Ophthalmol Vis Sci (1984) 0.84
Clinicians can agree in assessing relationship patterns in psychotherapy. The Core Conflictual Relationship Theme method. Arch Gen Psychiatry (1988) 0.84
Emergence of a dominant cytotoxic T lymphocyte antitumor effector from tumor-infiltrating cells in the anterior chamber of the eye. Cancer Immunol Immunother (1990) 0.84
Intracamerally induced concomitant immunity: mice harboring progressively growing intraocular tumors are immune to spontaneous metastases and secondary tumor challenge. J Immunol (1983) 0.84
Monoclonal IgA antibodies protect against Acanthamoeba keratitis. Exp Eye Res (1999) 0.84
Alloantigen presentation to the anterior chamber of the eye subverts specific in vitro cell-mediated immune responses. Transplantation (1982) 0.83
The differential effects of donor versus host Langerhans cells in the rejection of MHC-matched corneal allografts. Transplantation (1991) 0.83
Role of epidermal growth factor receptor in the metastasis of intraocular melanomas. Invest Ophthalmol Vis Sci (1998) 0.83
Enucleation in consort with immunologic impairment promotes metastasis of intraocular melanomas in mice. Invest Ophthalmol Vis Sci (1984) 0.82
Differential roles of CD8+ and CD8- T lymphocytes in corneal allograft rejection in 'high-risk' hosts. Am J Transplant (2006) 0.82
Rejection of intraocular tumors from transgenic mice by tumor-infiltrating lymphocytes. Curr Eye Res (1994) 0.81
Capacity of simian virus 40 T antigen to induce self-tolerance but not immunological privilege in the anterior chamber of the eye. Transplantation (1994) 0.81
Efficacy of tumor-infiltrating lymphocytes in the treatment of hepatic metastases arising from transgenic intraocular tumors in mice. Invest Ophthalmol Vis Sci (1995) 0.81
In situ suppression of delayed-type hypersensitivity: another mechanism for sustaining the immune privilege of the anterior chamber. Immunology (1991) 0.81
T cell subsets in the immune rejection of murine heterotopic corneal allografts. Invest Ophthalmol Vis Sci (1986) 0.81
Advent of objective measures of the transference concept. J Consult Clin Psychol (1986) 0.81
Aqueous humor-borne factor upregulates Bcl-2 expression in corneal endothelial cells. Curr Eye Res (1998) 0.81
Effect of prolonged use of inhaled steroids on the cellular immunity of children with asthma. J Allergy Clin Immunol (1995) 0.80
The nature of antigen in the eye has a profound effect on the cytokine milieu and resultant immune response. Eur J Immunol (1998) 0.80
Role of fas ligand in uveal melanoma-induced liver damage. Graefes Arch Clin Exp Ophthalmol (2001) 0.80